US HB2426 | 2015-2016 | 114th Congress
Status
Sponsorship: Partisan Bill (Republican 1)
Status: Introduced on May 19 2015 - 25% progression, died in committee
Action: 2015-05-22 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 19 2015 - 25% progression, died in committee
Action: 2015-05-22 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act with respect to easing regulatory burden with respect to certain class I and class II devices. This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA), not later than 120 days after enactment of the 21st Century Cures Act (H.B. 6, a bill introduced on May 19, 2015), to identify types of class I medical devices (devices that do not need special controls to assure their safety and effectiveness) for which a report is no longer needed prior to marketing to provide reasonable assurance of safety and effectiveness. (Currently, a report is needed for a class I device only if the device is of substantial importance in preventing impairment of human health or if it presents a potential unreasonable risk of illness or injury.) Not later than 180 days after enactment of the 21st Century Cures Act, the FDA must publish a list of types of class II medical devices (devices that need special controls to assure their safety and effectiveness) for which a report is no longer needed prior to marketing to provide reasonable assurance of safety and effectiveness. (Currently, such a list must be published each time the FDA exempts a type of class II device from the reporting requirement.) The public comment period for such an exemption is extended to 60 days.
Title
To amend the Federal Food, Drug, and Cosmetic Act with respect to easing regulatory burden with respect to certain class I and class II devices.
Sponsors
| Rep. John Shimkus [R-IL] |
History
| Date | Chamber | Action |
|---|---|---|
| 2015-05-22 | House | Referred to the Subcommittee on Health. |
| 2015-05-19 | House | Referred to the House Committee on Energy and Commerce. |
| 2015-05-19 | House | Introduced in House |
Same As/Similar To
HB6 (Related) 2015-07-13 - Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
SB2737 (Related) 2016-03-17 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
SB2737 (Related) 2016-03-17 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
Administrative law and regulatory procedures
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Government information and archives
Health
Health technology, devices, supplies
Product safety and quality
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Government information and archives
Health
Health technology, devices, supplies
Product safety and quality
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/114th-congress/house-bill/2426/all-info |
| Text | https://www.congress.gov/114/bills/hr2426/BILLS-114hr2426ih.pdf |
